CTSO (CytoSorbents Corp.) Prakiraan pendapatan perusahaan
Revenue growth for Cytosorbents relies on the recognized benefits of sorbents for sepsis and insurance coverage. The target product sales level demonstrates this trend, where the value of 0.04 serves as the current metric. Stable demand is driven by physicians' habituation to the cartridges, while the protection of synthesis technologies amid partial plastic outsourcing minimizes production risks.
Rincian analitis lan laporan data perusahaan CytoSorbents Corp. (CTSO)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Cytosorbents|CTSO - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Cytosorbents|CTSO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku CytoSorbents Corp|CTSO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Cytosorbents|Indikator likuiditas cepet cytosorbents.com
- statistik bathi lan rasio pasar:
CTSO - Bathi pungkasan|Proyeksi bathi mangsa ngarep Cytosorbents|CTSO - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Cytosorbents|CTSO - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CytoSorbents Corp|CTSO - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Cytosorbents|CTSO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cytosorbents.com|CTSO - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cytosorbents
- data dodolan lan asil:
Analisis fundamental perusahaan:CytoSorbents Corporation
This indicator reflects the market valuation of the enterprise's commercial potential, measuring capital density and the precision of management's strategic planning. An analysis of projected sales revenue allows for the verification of organic growth, excluding artificial price fluctuations. The metric discounts future cash flows, assessing the stability of the asset's fundamental value. For Cytosorbents (CTSO), this confirms stable demand for consumables. The regular use of cartridges in clinics transforms the business into a reliable source of recurring revenue.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan DXCM (DexCom, Inc.)|PEN (penumbrainc.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Novanta NOVT|HAE - Volume dodolan mangsa ngarep perusahaan|Inspire Sleep - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Procept|CNMD: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PLSE|INMD (InMode) - Prakiraan volume dodolan|Picard Medical Corp (PMI) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan SRDX|Volume dodolan mangsa ngarep perusahaan Eversense SENS|Prakiraan volume dodolan NPCE (NeuroPace, Inc.)|Prakiraan volume dodolan Tactile Systems Technology, Inc. TCMD|SNWV - Prakiraan pendapatan perusahaan|OM: Prakiraan pendapatan perusahaan|ELMD (smartvest.com) - Volume dodolan mangsa ngarep perusahaan|LENSAR Inc - Pendapatan mangsa ngarep perusahaan|RCEL (AVITA Medical, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Profound Medical Corporation PROF|Prakiraan pendapatan perusahaan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Prakiraan dodolan perusahaan|Apyx Medical Corporation - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan IceCure Medical Ltd. ICCM|Pulmonx Corp. - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan TELA Bio, Inc. TELA|Sensus Healthcare (SRTS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan ZYXI (Zynex Medical)|Prakiraan pendapatan perusahaan electroCore Inc|Volume dodolan mangsa ngarep perusahaan Vicarious Surgical Corp (RBOT)|Prakiraan volume dodolan IINN|ICU - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan IRIDEX IRIX|INBS: Prakiraan pendapatan perusahaan|XAIR: Volume dodolan mangsa ngarep perusahaan|Profusa, Inc - Prakiraan volume pendapatan perusahaan|SSKN: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan GlucoTrack Inc.|Volume dodolan mangsa ngarep perusahaan NAOV|Volume dodolan sing dikarepake perusahaan Venus Concept Inc VERO|Volume dodolan mangsa ngarep perusahaan NUWE (CHF Solutions)|Prakiraan volume pendapatan perusahaan AEMD|Prakiraan pendapatan perusahaan Asensus Surgical ASXC|avinger.com (AVGR) - Volume dodolan sing dikarepake perusahaan|BSGM - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Cutera Inc. CUTR|Know Labs Corp (KNW) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Inari Medical Corp (NARI)|Prakiraan pendapatan perusahaan Nevro Corp.|RSLS: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan SILK
